These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9935015

  • 1. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.
    Mickelson JK, Ali MN, Kleiman NS, Lakkis NM, Chow TW, Hughes BJ, Smith CW.
    J Am Coll Cardiol; 1999 Jan; 33(1):97-106. PubMed ID: 9935015
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.
    Simon DI, Xu H, Ortlepp S, Rogers C, Rao NK.
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):528-35. PubMed ID: 9102172
    [Abstract] [Full Text] [Related]

  • 5. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris.
    Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S.
    Am J Cardiol; 2000 Nov 15; 86(10):1057-62. PubMed ID: 11074199
    [Abstract] [Full Text] [Related]

  • 6. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A, Wendel HP, Azevedo R, Ziemer G.
    Eur J Cardiothorac Surg; 2005 Apr 15; 27(4):617-21. PubMed ID: 15784360
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
    Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Pieper K, Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR, Frelinger AL, Michelson AD.
    Am Heart J; 2001 Nov 15; 142(5):790-8. PubMed ID: 11685164
    [Abstract] [Full Text] [Related]

  • 9. [Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
    Hézard N, Metz D, Garnotel R, Droullé C, Potron G, Nguyen P.
    J Mal Vasc; 2000 Dec 15; 25(5):343-348. PubMed ID: 11148396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity.
    Barnard MR, Linden MD, Frelinger AL, Li Y, Fox ML, Furman MI, Michelson AD.
    J Thromb Haemost; 2005 Nov 15; 3(11):2563-70. PubMed ID: 16241954
    [Abstract] [Full Text] [Related]

  • 12. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty.
    Konstantopoulos K, Kamat SG, Schafer AI, Bañez EI, Jordan R, Kleiman NS, Hellums JD.
    Circulation; 1995 Mar 01; 91(5):1427-31. PubMed ID: 7867183
    [Abstract] [Full Text] [Related]

  • 13. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction.
    Neumann FJ, Zohlnhöfer D, Fakhoury L, Ott I, Gawaz M, Schömig A.
    J Am Coll Cardiol; 1999 Nov 01; 34(5):1420-6. PubMed ID: 10551687
    [Abstract] [Full Text] [Related]

  • 14. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.
    Fredrickson BJ, Turner NA, Kleiman NS, Graziadei N, Maresh K, Mascelli MA, Effron MB, McIntire LV.
    Circulation; 2000 Mar 14; 101(10):1122-9. PubMed ID: 10715258
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
    Inoue T, Uchida T, Sakuma M, Imoto Y, Ozeki Y, Ozaki Y, Hikichi Y, Node K.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1408-14. PubMed ID: 15464320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty.
    Ahnadi CE, Boughrassa FF, Chapman-Montgomery ES, Poisson V, Gervais A, Okrongly D, Grant AM.
    Thromb Haemost; 2004 Dec 06; 92(6):1207-13. PubMed ID: 15583725
    [Abstract] [Full Text] [Related]

  • 20. Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood.
    de Rossi LW, Horn NA, Hecker KE, Robitzsch T, Hutschenreuter G, Rossaint R.
    Anesthesiology; 2002 Jan 06; 96(1):117-24. PubMed ID: 11753011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.